Protein Therapeutics, Inc. Company Profile

11:17 EDT 20th March 2018 | BioPortfolio

Protein Therapeutics, Inc. was founded in 1997 to discover and develop new therapies for chronic diseases.The initial focus of the company is to develop an oral formulation of human immunoglobulin (IgPO) to treat adult and juvenile rheumatoid arthritis, crippling diseases that affect more than 2.1 million people in the United States.Upon successful completion of this goal, Protein Therapeutics will explore other applications for immune replacement therapy, including Crohn's disease, ulcerative colitis, and autoimmune hearing loss


Suite 202, 2761 N. Country Club Road
United States of America


Phone: 520-574-1632
Fax: 520-844-1187

News Articles [1638 Associated News Articles listed on BioPortfolio]

What You Need to Know About Relay Therapeutics

Based in Cambridge, MA and founded in February 2016, Relay Therapeutics focuses on developing therapeutics based on protein motion.

Anima Biotech: Translation Control Therapeutics

Anima Biotech is pioneering Translation Control Therapeutics, a new class of drugs that control protein translation. Yochi Slonim discusses with Fintan Walton thier novel drug discovery platform that ...

Pfizer and Sangamo to develop zinc finger protein therapy for ALS

Pfizer has partnered with US-based biotechnology firm Sangamo Therapeutics to use zinc finger protein transcription factors (ZFP-TFs) for the development...Read More... The post Pfizer and Sangamo to ...

Belgian Biotech and Roche Take on Neurological and Developmental Disorders

Confo Therapeutics has joined forces with Roche to develop new small molecule agonists of a G-protein coupled receptor to treat neurological and developmental disorders. Confo Therapeutics is developi...

Syndesi Therapeutics licenses UCB's SV2A modulators

Recently formed Belgian biotech Syndesi Therapeutics SA licensed exclusive worldwide rights to UCB's pipeline of synaptic vesicle protein SV2A modulators.

Phenotype-specific recombinant haptoglobin polymers co-expressed with C1r-like protein as optimized hemoglobin-binding therapeutics

Preclinical studies have evaluated haptoglobin (Hp) polymers from pooled human plasma as a therapeutic protein to attenuate toxic effects of cell-free hemoglobin (Hb). Proof of concept studies have de...

Drugging The Undruggable: Kymera's Targeted Protein Degradation

Kymera Therapeutics is a new startup launching in the targeted protein degradation (TPD) space, focusing on discovering and developing novel first-in-class medicines that offer unique degradation-indu...

Roche signs GPCR discovery deal with Confo Therapeutics

Confo Therapeutics NV licensed Roche exclusive rights to discover, develop, manufacture, and sell small-molecule G-protein coupled receptor (GPCR) agonists for neurological and developmental disorders...

PubMed Articles [2409 Associated PubMed Articles listed on BioPortfolio]

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Non-protein biologic therapeutics.

While the therapeutic biologics are dominated by therapeutic proteins, particularly monoclonal antibodies, a wide range of non-protein therapeutic biologics are rapidly gaining ground both in clinical...

Dry-powder formulations of non-covalent protein complexes with linear or miktoarm copolymers for pulmonary delivery.

Pulmonary delivery of protein therapeutics has considerable clinical potential for treating both local and systemic diseases. However, poor protein conformational stability, immunogenicity and protein...

Designing anti-Zika virus peptides derived from predicted human-Zika virus protein-protein interactions.

The production of anti-Zika virus (ZIKV) therapeutics has become increasingly important as the propagation of the devastating virus continues largely unchecked. Notably, a causal relationship between ...

On the glycosylation aspects of biosimilarity.

The recent expiration of several protein therapeutics opened the door for biosimilar development. Biosimilars are biologic medical products that are similar but not identical copies of already-authori...

Clinical Trials [2006 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Dietary Protein Requirement of Elderly Men and Women

The purpose of this study was to assess the effect of age on the estimated average requirement and adequate allowance for dietary protein.

Companies [1849 Associated Companies listed on BioPortfolio]

Perlan Therapeutics

Perlan Therapeutics is an innovative developer of protein-based pharmaceuticals. The company's proprietary Multi-Valenceâ„¢ technology platform is the basis for the development of cost-effective p...


Since 1997, Xencor has built the most powerful protein engineering technology platform in the biotechnology industry. Its versatility is evidenced by our success in developing two classes of superior ...

Protein Therapeutics, Inc.

Protein Therapeutics, Inc. was founded in 1997 to discover and develop new therapies for chronic diseases.The initial focus of the company is to develop an oral formulation of human immunoglobulin (Ig...

PX’Therapeutics SA

PX’Therapeutics, located in Grenoble and Lyon (France) and with a sales office in Cambridge (MA, USA), offers early stage research and cGMP manufacturing contracts focusing o...

Proteostasis Therapeutics

Proteostasis Therapeutics is discovering “Proteostasis Regulators” (PRs), small molecule drugs that restore proper protein function to treat neurodegenerative, metabolic...

More Information about "Protein Therapeutics, Inc." on BioPortfolio

We have published hundreds of Protein Therapeutics, Inc. news stories on BioPortfolio along with dozens of Protein Therapeutics, Inc. Clinical Trials and PubMed Articles about Protein Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Protein Therapeutics, Inc. Companies in our database. You can also find out about relevant Protein Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...

Corporate Database Quicklinks

Searches Linking to this Company Record